The -1131T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men

American Journal of Clinical Nutrition

Volumn 80, Issue 4, 2004, Pages 832-840

  Jang, Yangsoo ^a,b   Ji, Young Kim ^b   Oh, Yoen Kim ^b   Jong, Eun Lee ^c   Cho, Hongkeun ^b   Ordovas, Jose M ^d   Lee, Jong Ho ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c DNA Link Inc   (South Korea)

^d TUFTS UNIVERSITY   (United States)

Author keywords

Apolipoprotein A5 gene; C reactive protein; Cardiovascular disease risk; DNA damage; Lipid peroxidation; Postprandial lipid response

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; APOLIPOPROTEIN A5; C REACTIVE PROTEIN; CHYLOMICRON; DNA; FATTY ACID; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN; APOLIPOPROTEIN A;

ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA DAMAGE; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; KOREA; LIPID PEROXIDATION; LYMPHOCYTE; OXIDATION; OXIDATIVE STRESS; POSTPRANDIAL STATE; PROMOTER REGION; RISK FACTOR; STATISTICAL SIGNIFICANCE; ADULT; BLOOD; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; GENE FREQUENCY; GENETICS; MALE; MIDDLE AGED; PHYSIOLOGY;

ANIMALIA;

ADULT; ALLELES; APOLIPOPROTEINS; APOLIPOPROTEINS A; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DNA DAMAGE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; KOREA; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; RISK FACTORS; TRIGLYCERIDES;

EID: 5144231856     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/80.4.832     Document Type: Article

References (43)

1. South Korea National Statistical Office. Annual report on the cause of death statistics. Seoul, South Korea: National Statistical Office, 2000.
2. South Korean Ministry of Health and Social Affairs. 2001 national health and nutrition survey: health examination. Seoul, South Korea: Ministry of Health and Welfare, 2002.
3. South Korean Ministry of Health and Social Affairs. 2001 national health and nutrition survey: overview. Seoul, South Korea: Ministry of Health and Welfare, 2002.
4. Connelly PW, Petrasovits A, Stachenko S, MacLean DR, Little JA, Chockalingam A. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999;15:428-33.
5. Tai ES, Emmanuel SC, Chew SK, Tan BY, Tan CE. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes 1999;48:1088-92.
6. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002;11:3031-8.
7. Evans D, Buchwald A, Beil FU. The single nucleotide polymorphism -1131T→C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 2003;81:645-54.
8. Nabika T, Nasreen S, Kobayashi S, Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 2002;165:201-4.
9. Endo K, Yanagi H, Araki J, Hirano C, Yamakawa-Kobayashi K, Tomura S. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 2002;111:570-2.
10. Lai CQ, Tai ES, Tan CE, et al. The apolipoprotein A5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003;44:2365-73.
11. Ribalta J, Figuera L, Fernandez-Ballart J, et al. Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 2002;48:1597-600.
12. Masana L, Ribalta J, Salazar J, Fernandez-Ballart J, Joven J, Cabezas MC. The apolipoprotein AV gene and diurnal triglyceridaemia in normolipidaemic subjects. Clin Chem Lab Med 2003;41:517-21.
13. Griffin BA, Caslake MJ, Yip B, et al. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis 1990;83:59-67.
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
15. Campins-Falco P, Sevillano-Cabeza A, Llobat-Estelles M. Kinetic and chemometric studies of the determination of creatinine using the Jaffe reaction. Part 2. Application to human serum samples: kinetic behaviour and chemometric evaluation of the determination. Analyst 1989;114:603-7.
16. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993;84:407-12.
17. Green M, Low J, Haarcourt SA, et al. UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and Xeroderma pigmentosum donors in the comet assay: a potential diagnostic technique. Mutat Res 1992;279:137-44.
18. Eda S, Kaufmann J, Roos W, Pohl S. Development of a new microparticle-enhanced turbidimetric assay for C-reactive protein with superior features in analytical sensitivity and dynamic range. J Clin Lab Anal 1998;12:137-44.
19. Christian JL, Greger JL. Nutrition for Living. Redwood City, CA: Benjamin/Cummings, 1994:111.
20. The American Dietetic Association. Handbook of clinical dietetics. 2nd ed. New Haven, CT: Yale University Press, 1992:5-39.
21. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001;294:169-73.
22. Rensen P, Schaap F, Voshol P, et al. Apolipoprotein AV expression in mice ameliorates the hyperlipidemia associated with APOE2 and APOE3Leiden by stimulating LPL-mediated VLDL-triglyceride hydrolysis. Atherosclerosis 2003;4:s229.
23. Martin S, Nicaud V, Humphries SE, Talmud PJ. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochemica et Biophsica Acta 2003;1637:217-25.
24. Miesenbock G, Patsch JR. Postprandial hyperlipidemia: the search for the atherogenic lipoprotein. Curr Opin Lipidol 1992;2:196-201.
25. Lagrost L, Gambert P, Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 1994;14:1327-36.
26. Karpe F, Tornvall P, Olivecrona T, Steiner G, Carlson LA, Hamsten A. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 1993;4:98:33-49.
27. Callow J, Summers LK, Bradshaw H, Frayn KN. Changes in LDL particle composition after the consumption of meals containing different amounts and types of fat. Am J Clin Nutr 2002;76:345-50.
28. Koba S, Hirano T, Murayama S, et al. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis 2003;170:131-40.
29. Lemieux I, Couillard C, Pascot A, et al. The small, dense LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis 2000;153:423-32.
30. Griffin BA, Freeman DJ, Tait GW, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-53.
31. Tchernof A, Lamarche B, Prud'Homme D, et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996;19:629-37.
32. Tan KC, Cooper MB, Ling KL, et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 1995;113:273-87.
33. Cho HK, Shin G, Ryu SK, et al. Regulation of small dense LDL concentration in Korean and Scottish men and women. Atherosclerosis 2002;164:187-93.
34. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002;106:2530-2.
35. Morrow JD. Is oxidant stress a connection between obesity and atherosclerosis? Arterioscler Thromb Vasc Biol 2003;23:368-70.
36. Jang Y, Kim OY, Ryu HJ, et al. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J Lipid Res 2003;44:2356-64.
37. Llobat-Estelles M, Sevillano-Cabeza A, Campins-Falco P. Kinetic and chemometric studies of the determination of creatinine using the Jaffe reaction Part I. Kinetics of the reaction: analytical conclusion. Analyst 1989;114:597-602.
38. Richelle M, Turini ME, Guidoux R, Tavazzi I, Metairon S, Fay LB. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett 1999;459:259-62.
39. Mendoza-Nunez VM, Sanchez-Rodriguez MA, Retana-Ugalde R, Vargas-Guadarrama LA, Altamirano-Lozano MA. Total antioxidant levels, gender, and age as risk factors for DNA damage in lymphocytes of the elderly. Mech Aging Dev 2001;122:835-47.
40. Moller P, Loft S. Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies. Am J Clin Nutr 2002;76:303-10.
41. Dhawan A, Mathur N, Seth PK. The effect of smoking and eating habits on DNA damage in Indian population as measured in the Comet assay. Mutat Res 2004;474:121-8.
42. Piperakis SM, Visvardis EE, Sagnou M, Tassiou AM. Effects of smoking and aging on oxidative DNA damage of human lymphocytes. Carcinogenesis 1998;19:695-8.
43. Genoux A, Gervois P, Vu-Dac N, et al. Apolipoprotein A5 in inflammatory responsive gene down-regulated by tumor necrosis factor α and interleukin-1. Atherosclerosis 2003;2:s214 (abstr).